Premium
Clinical outcomes of IDH2 ‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib
Author(s) -
Patel Anand A.,
Cahill Kirk,
CharnotKatsikas Angella,
Liu Hongtao,
Gurbuxani Sandeep,
Thirman Michael,
Kosuri Satyajit,
Artz Andrew S.,
Larson Richard A.,
Stock Wendy,
Segal Jeremy,
Odenike Olatoyosi
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16709
Subject(s) - medicine , idh2 , oncology , cancer research , mutation , biology , genetics , gene , idh1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom